Cargando…
A synergetic effect of BARD1 mutations on tumorigenesis
To date, a large number of mutations have been screened from breast and ovarian cancer patients. However, most of them are classified into benign or unidentified alterations due to their undetectable phenotypes. Whether and how they could cause tumors remains unknown, and this significantly limits d...
Autores principales: | Li, Wenjing, Gu, Xiaoyang, Liu, Chunhong, Shi, Yanyan, Wang, Pan, Zhang, Na, Wu, Rui, Leng, Liang, Xie, Bingteng, Song, Chen, Li, Mo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902612/ https://www.ncbi.nlm.nih.gov/pubmed/33623049 http://dx.doi.org/10.1038/s41467-021-21519-3 |
Ejemplares similares
-
The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP
por: Yue, Wei, et al.
Publicado: (2022) -
BARDES coming of age?
Publicado: (2022) -
Cancer predisposing BARD1 mutations in breast-ovarian cancer families
por: Ratajska, Magdalena, et al.
Publicado: (2012) -
Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?
por: Stempa, Klaudia, et al.
Publicado: (2021) -
Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability
por: Pilyugin, Maxim, et al.
Publicado: (2016)